BRPI0604024A - cancer prevention foods and jasmonate based pharmaceutical compositions - Google Patents

cancer prevention foods and jasmonate based pharmaceutical compositions

Info

Publication number
BRPI0604024A
BRPI0604024A BRPI0604024A BRPI0604024A BR PI0604024 A BRPI0604024 A BR PI0604024A BR PI0604024 A BRPI0604024 A BR PI0604024A BR PI0604024 A BRPI0604024 A BR PI0604024A
Authority
BR
Brazil
Prior art keywords
pharmaceutical compositions
jasmonate
foods
cancer prevention
based pharmaceutical
Prior art date
Application number
Other languages
Portuguese (pt)
Inventor
Jose Emilio Fehr Pereira Lopes
Maria Lucia Bueno Trindade
Edivaldo Domingues Velini
Original Assignee
Beyond Lifescience Pesquisa De
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beyond Lifescience Pesquisa De filed Critical Beyond Lifescience Pesquisa De
Priority to BRPI0604024 priority Critical patent/BRPI0604024A/en
Publication of BRPI0604024A publication Critical patent/BRPI0604024A/en

Links

Landscapes

  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

ALIMENTOS PARA A PREVENçãO DO CáNCER E COMPOSIçõES FARMACêUTICAS à BASE DO JASMONATO. A presente patente de invenção apresenta combinações de jasmonatos como uma droga potente, na produção e/ou acúmulo de substâncias preventivas do câncer em alimentos de qualquer espécie e composições farmacêuticas com ação cicatrizante, bacteriostática, cosmética, analgésica. entre outras. Os alimentos e as composições farmacêuticas apresentadas não são tóxicos para células sadias por possuírem como ingrediente ativo formas de jasmonato, hormónio anti-estresse de plantas.CANCER PREVENTION FOOD AND JASMONATE BASED PHARMACEUTICAL COMPOSITIONS. The present patent discloses combinations of jasmonates as a potent drug in the production and / or accumulation of cancer preventive substances in foods of any kind and pharmaceutical compositions with healing, bacteriostatic, cosmetic, analgesic action. among others. The foods and pharmaceutical compositions presented are not toxic to healthy cells because they have as active ingredient forms of jasmonate, anti-stress hormone of plants.

BRPI0604024 2006-09-01 2006-09-01 cancer prevention foods and jasmonate based pharmaceutical compositions BRPI0604024A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BRPI0604024 BRPI0604024A (en) 2006-09-01 2006-09-01 cancer prevention foods and jasmonate based pharmaceutical compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BRPI0604024 BRPI0604024A (en) 2006-09-01 2006-09-01 cancer prevention foods and jasmonate based pharmaceutical compositions

Publications (1)

Publication Number Publication Date
BRPI0604024A true BRPI0604024A (en) 2008-04-22

Family

ID=39309848

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0604024 BRPI0604024A (en) 2006-09-01 2006-09-01 cancer prevention foods and jasmonate based pharmaceutical compositions

Country Status (1)

Country Link
BR (1) BRPI0604024A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010006392A2 (en) * 2008-07-15 2010-01-21 Fehr Pereira Lopes Jose E Pharmaceutical formulation between jasmonates and it derivatives and nanocarries or microcarri es
US8883220B2 (en) 2011-09-16 2014-11-11 Nanocare Technologies, Inc. Compositions of jasmonate compounds
US10314918B2 (en) 2014-12-31 2019-06-11 Nanocare Technologies, Inc. Jasmonate derivatives and compositions thereof

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010006392A2 (en) * 2008-07-15 2010-01-21 Fehr Pereira Lopes Jose E Pharmaceutical formulation between jasmonates and it derivatives and nanocarries or microcarri es
WO2010006392A3 (en) * 2008-07-15 2010-03-18 Fehr Pereira Lopes Jose E Pharmaceutical composition comprising jasmonates
US8883220B2 (en) 2011-09-16 2014-11-11 Nanocare Technologies, Inc. Compositions of jasmonate compounds
US9592305B2 (en) 2011-09-16 2017-03-14 Nanocare Technologies, Inc. Compositions of jasmonate compounds and methods of use
US10328155B2 (en) 2011-09-16 2019-06-25 Nanocare Technologies, Inc. Compositions of jasmonate compounds and methods of use
US10314918B2 (en) 2014-12-31 2019-06-11 Nanocare Technologies, Inc. Jasmonate derivatives and compositions thereof

Similar Documents

Publication Publication Date Title
BR112014011841A2 (en) hydrophobic drug delivery material, method for producing the same and methods for delivering a drug delivery composition
BR112012005044A2 (en) compositions comprising tramadol and celecoxib in the treatment of pain.
WO2012142511A3 (en) Orthomolecular compositions and their use in stabilizing the extracellular matrix
EA201401028A1 (en) PHARMACEUTICAL COMPOSITION, CONTAINING EMAGOGLIFLOZIN AND MEDICINES FOR OBESITY
CL2010001260A1 (en) Pharmaceutical composition comprising a salt of strontium and vitamin D and a cyclodextrin, where the mass ratio between the amount of vitamin D and the amount of cyclodextrin is between 1/40 and 1/800, useful for treating or preventing osteoporosis.
UY32989A (en) CONCENTRATED THERAPEUTIC PHOSPHOLIPID COPOSITIONS
CO5640037A2 (en) DERIVATIVES OF QUINAZOLINE FOR THE TREATMENT OF CANCER
GT200600260A (en) BENZAMIDA DERIVATIVES AND USES RELATED TO THE SAME
SV2010003674A (en) DIHYDROPIRAZOLONAS REPLACED AS INHIBITORS OF HIF-PROPIL-4-HYDROXYLASE
MY167691A (en) A pharmaceutical spray composition comprising a vitamin d analogue and a corticosteroid
BR112014005358A2 (en) pain relief composition comprising a selective trpv1 agonist, and its manufacture and use
CL2007001724A1 (en) USE OF A STROGEN FOR THE TREATMENT OF DISEASES, CONDITIONS OR SYMPTOMS ASSOCIATED WITH DEFICIENT LEVELS OF STROGENS IN A WOMAN; PHARMACEUTICAL COMPOSITION THAT INCLUDES DAILY DOSAGE UNITS OF ESTRADIOL HEMIDRATE> 0.75 AND 1
BR112012016330B8 (en) ampk thieno[2,3-b]pyridinedione activators and pharmaceutical composition comprising the same
BRPI0819152B8 (en) topical pharmaceutical composition
CL2007003480A1 (en) COMPOUNDS DERIVED FROM TIAZOLO [5,4-C] PIRIDIN-4-ONA REPLACED; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE IN THE TREATMENT OR PREVENTION OF OBESITY-RELATED DISEASES, AS FOOD DISORDERS, DIAB
UY30215A1 (en) CHROMANOL DERIVATIVES REPLACED, PROCEDURES FOR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND APPLICATIONS
CL2007002875A1 (en) Pharmaceutical composition covered by a film comprising capecitabine and at least one disintegrant, useful in the treatment of cancer for patients who have difficulty swallowing oral solid dosage forms.
SV2009002953A (en) NEW ACICLIC FUROPIRIMIDINE DERIVATIVES SUBSTITUTED AND ITS USE
CR9911A (en) PHARMACEUTICAL COMPOSITIONS THAT INCLUDE COMBINATIONS OF ANALGESIC AND ANTI-CONVULSIVANTS FOR THE TREATMENT OF ACUTE AND CHRONIC PAIN
NI201300045A (en) APOPTOSIS INHIBITORS AND USES OF THEM.
DE602006009259D1 (en) PHARMACEUTICAL COMPOSITION COMPRISING ORGANIC ORGANIC FUEL
IL205290A (en) Variant of human neurturin protein, or a biologically active fragment thereof, pharmaceutical compositions comprising it and use thereof in the manufacture of medicaments for therapy
SV2006002384A (en) PIRAZOLO PIRIDINAS REPLACED, COMPOSITIONS THAT CONTAIN THEM, MANUFACTURING AND USE PROCEDURE
MA32635B1 (en) Pharmaceutical product and associated treatment
BRPI0604024A (en) cancer prevention foods and jasmonate based pharmaceutical compositions

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired